Jerome D. Goldberg

Array ( [id] => 3934010 [patent_doc_number] => 05929066 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Chromium/biotin treatment of Type II diabetes' [patent_app_type] => 1 [patent_app_number] => 9/110511 [patent_app_country] => US [patent_app_date] => 1998-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1980 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929066.pdf [firstpage_image] =>[orig_patent_app_number] => 110511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4289253 [patent_doc_number] => 06211239 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Method for treating or preventing breast cancer or leukemia using 6-[3-[1-adamantyl]-4-hydroxyphenyl]-2-naphthalene carboxylic acid (AHPN)' [patent_app_type] => 1 [patent_app_number] => 9/011323 [patent_app_country] => US [patent_app_date] => 1998-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 25 [patent_no_of_words] => 9700 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211239.pdf [firstpage_image] =>[orig_patent_app_number] => 011323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4405006 [patent_doc_number] => 06309672 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Anti-cancer therapy agent of arsenic hexoxide (As4O6) of a natural chemical substance and its pharmaceutical composition' [patent_app_type] => 1 [patent_app_number] => 9/105086 [patent_app_country] => US [patent_app_date] => 1998-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 62 [patent_no_of_words] => 9176 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309672.pdf [firstpage_image] =>[orig_patent_app_number] => 105086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1348836 [patent_doc_number] => 06579893 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-17 [patent_title] => 'Use of troglitazone and related compounds for the treatment of cancer' [patent_app_type] => B1 [patent_app_number] => 09/102164 [patent_app_country] => US [patent_app_date] => 1998-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11076 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/579/06579893.pdf [firstpage_image] =>[orig_patent_app_number] => 09102164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1369165 [patent_doc_number] => 06566351 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => 'Malignant tumor metastasis inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/091185 [patent_app_country] => US [patent_app_date] => 1998-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 2879 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566351.pdf [firstpage_image] =>[orig_patent_app_number] => 09091185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4104249 [patent_doc_number] => 06100301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Combination therapy to treat osteoporosis-polyphosphonates and estrogen agonists' [patent_app_type] => 1 [patent_app_number] => 9/092100 [patent_app_country] => US [patent_app_date] => 1998-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6650 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/100/06100301.pdf [firstpage_image] =>[orig_patent_app_number] => 092100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3933887 [patent_doc_number] => 05929057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Pharmaceutical composition for the treatment of leukemia containing 9-cis-retinoic acid-.alpha.-tocopherol ester' [patent_app_type] => 1 [patent_app_number] => 9/092143 [patent_app_country] => US [patent_app_date] => 1998-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6778 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929057.pdf [firstpage_image] =>[orig_patent_app_number] => 092143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4311809 [patent_doc_number] => 06316425 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Therapeutic agents' [patent_app_type] => 1 [patent_app_number] => 8/983483 [patent_app_country] => US [patent_app_date] => 1998-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 8145 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316425.pdf [firstpage_image] =>[orig_patent_app_number] => 983483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3906660 [patent_doc_number] => 05898034 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-27 [patent_title] => 'Psoriasis medication and application for remission and/or cure of plaque psoriasis' [patent_app_type] => 1 [patent_app_number] => 9/083627 [patent_app_country] => US [patent_app_date] => 1998-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 695 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/898/05898034.pdf [firstpage_image] =>[orig_patent_app_number] => 083627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4190262 [patent_doc_number] => 06153603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-28 [patent_title] => 'Method of treating angiogenesis in tumor tissue' [patent_app_type] => 1 [patent_app_number] => 9/093074 [patent_app_country] => US [patent_app_date] => 1998-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6192 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/153/06153603.pdf [firstpage_image] =>[orig_patent_app_number] => 093074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237903 [patent_doc_number] => 06166029 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Method for treating cancer with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof' [patent_app_type] => 1 [patent_app_number] => 9/080722 [patent_app_country] => US [patent_app_date] => 1998-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 17 [patent_no_of_words] => 6157 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166029.pdf [firstpage_image] =>[orig_patent_app_number] => 080722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171534 [patent_doc_number] => 06140346 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Treatment of cancer with thalidomide alone or in combination with other anti-cancer agents' [patent_app_type] => 1 [patent_app_number] => 9/071813 [patent_app_country] => US [patent_app_date] => 1998-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7972 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140346.pdf [firstpage_image] =>[orig_patent_app_number] => 071813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4252140 [patent_doc_number] => 06207666 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Method for treating a patient having precancerous lesion with 4-phenylphthalazine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/065662 [patent_app_country] => US [patent_app_date] => 1998-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7699 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 249 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207666.pdf [firstpage_image] =>[orig_patent_app_number] => 065662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4097147 [patent_doc_number] => 06099845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-08 [patent_title] => 'Process for the preparation of Rhus verniciflua extract and anti-cancer composition containing same' [patent_app_type] => 1 [patent_app_number] => 9/063853 [patent_app_country] => US [patent_app_date] => 1998-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5396 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/099/06099845.pdf [firstpage_image] =>[orig_patent_app_number] => 063853 [rel_patent_id] =>[rel_patent_doc_number] =>)